Chinook Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Chinook Therapeutics

08/11/2021 22:01

* Chinook Therapeutics Inc  KDNY.OQ  reported a quarterly
adjusted loss of 69 cents​​ per share for the quarter ended in
September. The mean expectation of six analysts for the quarter
was for a loss of 84 cents per share.
* Revenue fell 99.9% to $4.00 thousand from a year ago; 
analysts expected $41.67 thousand. 
* Chinook Therapeutics Inc's reported EPS for the quarter was a
loss of 69 cents​.
* The mean earnings estimate of analysts had fallen by
about 10.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Chinook Therapeutics Inc shares had risen by 25.1% this
quarter and gained 0.6% so far this year.
* The company reported a quarterly loss of $30.7 million.
* Wall Street's median 12-month price target for Chinook
Therapeutics Inc is $33.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 8 at 10:01 p.m.
 ​All figures in US dollars unless otherwise stated